1. Home
  2. CLPS vs ELUT Comparison

CLPS vs ELUT Comparison

Compare CLPS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CLPS Incorporation

CLPS

CLPS Incorporation

SELL

Current Price

$1.06

Market Cap

36.0M

Sector

Technology

ML Signal

SELL

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.14

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPS
ELUT
Founded
2005
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0M
23.3M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CLPS
ELUT
Price
$1.06
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
14.8K
170.3K
Earning Date
01-01-0001
04-07-2026
Dividend Yield
12.62%
N/A
EPS Growth
N/A
10.14
EPS
N/A
N/A
Revenue
N/A
$24,375,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.50
52 Week High
$1.88
$3.46

Technical Indicators

Market Signals
Indicator
CLPS
ELUT
Relative Strength Index (RSI) 48.17 60.68
Support Level $0.90 $0.86
Resistance Level $1.08 $1.15
Average True Range (ATR) 0.05 0.13
MACD -0.02 -0.00
Stochastic Oscillator 13.33 61.64

Price Performance

Historical Comparison
CLPS
ELUT

About CLPS CLPS Incorporation

CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: